• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911612300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Cardiomyopathy (1764); Death (1802); Cardiogenic Shock (2262)
Event Date 01/04/2016
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause was unable to be determined.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that the patient died.In (b)(6) 2013, the patient presented due to unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed.The target lesion was a de novo and ostial lesion located in left internal mammary artery (lima) to distal left anterior descending (lad) artery with 80% stenosis and was 10mm long and reference vessel diameter of 3mm.The target lesion with direct placement of a 3.00x12mm promus element¿ plus stent with 0% residual stenosis.On the following day, the patient was discharged on aspirin.In (b)(6) 2015, the patient presented to the hospital with multiple cardiac arrests, and was in cardiogenic shock.The patient also had respiratory failure, renal failure, anoxic encephalopathy, severe ischemic cardiomyopathy, bullous lesions of staphylococcus epidermidis and pneumonia at the time of hospitalization.Multiple consults were involved including nephrology, critical care, infectious disease, neurology, and cardiology.The patient was intubated and put on ventilator support and was placed on pressors and broad spectrum antibiotics.Despite all aggressive measures, the patient's condition never improved.She was found to have hypoxic encephalopathy and never recovered.Four days after, the patient's family opted to withdraw care and the patient expired due to cardiac arrest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6278716
MDR Text Key65768377
Report Number2134265-2017-00048
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/02/2013
Device Model NumberH7493911612300
Device Catalogue Number39116-1230
Device Lot Number15520507
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age61 YR
-
-